- Home
- CTSO vs RGS Comparison
CTSO vs RGS Comparison
Compare CTSO & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- RGS
- Stock Information
- Founded
- CTSO 1997
- RGS 1922
- Country
- CTSO United States
- RGS United States
- Employees
- CTSO N/A
- RGS N/A
- Industry
- CTSO Medical/Dental Instruments
- RGS Other Consumer Services
- Sector
- CTSO Health Care
- RGS Consumer Discretionary
- Exchange
- CTSO Nasdaq
- RGS Nasdaq
- Market Cap
- CTSO 52.6M
- RGS 54.2M
- IPO Year
- CTSO N/A
- RGS 1991
- Fundamental
- Price
- CTSO $1.03
- RGS $23.18
- Analyst Decision
- CTSO Buy
- RGS
- Analyst Count
- CTSO 2
- RGS 0
- Target Price
- CTSO $5.50
- RGS N/A
- AVG Volume (30 Days)
- CTSO 134.9K
- RGS 9.0K
- Earning Date
- CTSO 08-12-2025
- RGS 08-27-2025
- Dividend Yield
- CTSO N/A
- RGS N/A
- EPS Growth
- CTSO N/A
- RGS N/A
- EPS
- CTSO N/A
- RGS 41.20
- Revenue
- CTSO $35,332,238.00
- RGS $199,112,000.00
- Revenue This Year
- CTSO $18.34
- RGS N/A
- Revenue Next Year
- CTSO $19.82
- RGS N/A
- P/E Ratio
- CTSO N/A
- RGS $0.61
- Revenue Growth
- CTSO 15.37
- RGS N/A
- 52 Week Low
- CTSO $0.71
- RGS $15.00
- 52 Week High
- CTSO $1.61
- RGS $35.50
- Technical
- Relative Strength Index (RSI)
- CTSO 49.00
- RGS 60.41
- Support Level
- CTSO $0.93
- RGS $21.76
- Resistance Level
- CTSO $1.39
- RGS $22.67
- Average True Range (ATR)
- CTSO 0.13
- RGS 0.94
- MACD
- CTSO -0.02
- RGS 0.03
- Stochastic Oscillator
- CTSO 34.92
- RGS 82.94
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.